Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schellhammer

Showing results (321-330 of 326) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 326 results.
Urology|January 1, 1997
Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM systemA R Vashi, K J Wojno, W Henricks, et al.
The Journal of Urology|December 22, 1999
Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety studyC G Roehrborn, J McConnell, J Bonilla, et al.
The New England Journal of Medicine|August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapyJuanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
The New England Journal of Medicine|April 5, 2013
Intermittent versus continuous androgen deprivation in prostate cancerMaha Hussain, Catherine M Tangen, Donna L Berry, et al.
Urology|September 25, 1997
Improved detection of recurrent bladder cancer using the Bard BTA stat TestM F Sarosdy, M A Hudson, W J Ellis, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registryOliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
Pageof 33

Showing results (321-330 of 326) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 326 results.
Urology|January 1, 1997
Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM systemA R Vashi, K J Wojno, W Henricks, et al.
The Journal of Urology|December 22, 1999
Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety studyC G Roehrborn, J McConnell, J Bonilla, et al.
The New England Journal of Medicine|August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapyJuanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
The New England Journal of Medicine|April 5, 2013
Intermittent versus continuous androgen deprivation in prostate cancerMaha Hussain, Catherine M Tangen, Donna L Berry, et al.
Urology|September 25, 1997
Improved detection of recurrent bladder cancer using the Bard BTA stat TestM F Sarosdy, M A Hudson, W J Ellis, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registryOliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
Pageof 33